11:30 AM IST (7:00 AM Colmar - France Time).
Building on a history of innovation in polymer science and capsule engineering, the Capsugel® brand, now part of Lonza, offers a suite of HPMC and alternate polymer capsules for the pharmaceutical world. Polymer science and engineering have opened a new era of functional development, which offers the potential for selecting the right capsule for different APIs. Capsugel® Vcaps® Plus capsules represent a unique and valuable contribution: they perform like gelatin but offer additional advantages, particularly a lower moisture content, which makes them excellent for hygroscopic and moisture-sensitive drugs and manufacturing processes. HPMC capsules are inert and robust against cross-linking or the effects of extreme storage conditions. Furthermore, Vcaps® Plus capsules have equivalent performance and appearance to that of gelatin capsules, offering new possibilities to product developers around the world.
Claire Tardy, Ph.D.
Research & Development Manager
Capsule Delivery Solutions,
Lonza Pharma & Biotech
Dr. Nicolas Madit
Business Development Manager
Lonza Pharma & Biotech
Who Should Attend ?Claire has been an integral part of the Capsugel® family for almost 20 years. She started as a Research Engineer in 1999. In 2007, she moved into the role of Head of Research and then 2017 Manager of Research & Development. Claire has a Ph.D. in Sciences of Polymers from Universities of Grenoble (France) and Leeds (UK).
After graduating as Engineer in Chemistry from Montpellier, Nicolas completed his PhD in organic and polymer sciences followed by a postdoctoral scholarship on synthesis of copolymers as specific transportation vector for drugs. Nicolas started his industrial career in the ink jet printing before joining Capsugel as research engineer and evolved in different departments from formulation, to Licaps production and now as Business development manager. During his career Nicolas wrote several articles and filed patents in different domains related to capsules.